BIOCOMPATIBILITY IN HEMAPHERESIS - BLOOD-COAGULATION

Authors
Citation
B. Bizzi et Ml. Foddai, BIOCOMPATIBILITY IN HEMAPHERESIS - BLOOD-COAGULATION, International journal of artificial organs, 16, 1993, pp. 209-213
Citations number
38
Categorie Soggetti
Engineering, Biomedical
ISSN journal
03913988
Volume
16
Year of publication
1993
Supplement
5
Pages
209 - 213
Database
ISI
SICI code
0391-3988(1993)16:<209:BIH-B>2.0.ZU;2-R
Abstract
Hemapheresis may influence the coagulation system with effects of acti vation and dilution. Dilution can lead to reduced levels of platelets, fibrinogen and antithrombin III. Activation initially causes increase d clotting activity, but the consumption of the activated factors gene rally induces a subsequent phase of hypocoagulability. In the donor, a pheresis diminishes platelet count and function, as well as the levels of many other clotting factors. Depletion of fibrinogen and antithrom bin III are less transient than others because their rates of synthesi s are lower. In spite of the wide variety in hemapheretic procedures, all of them (or at least, those that are the most commonly used) are a ssociated with similar activation phenomena, that appear to be mediate d by the formation of a fibrinogen layer on the artificial surfaces of the circuitry.